26/05/2026
Extended Data Submission Period for ABSINE Audit ‼️
Update: the submission deadline for the ABSINE Audit has been extended!
New deadline: 31 August 2026
We encourage ENT and Neurosurgical centres across Europe to participate and contribute to this important multicentre collaboration on sinogenic brain abscesses.
Together, we can strengthen evidence-based interdisciplinary care and improve patient outcomes.
For registration and further information:
Scan the QR code or [email protected]
05/05/2026
In the previous episode of The Valentin series on Physician Well-Being we’ve explored how our work impacts us — now it’s time for the next step.
Peer support: how we can actively support each other in everyday practice.
Even if your institution doesn’t offer support systems, change can start with us.
Let’s break the silence, support one another, and build a healthier way of working together.
📅 4-6-2026 20:00 CET | ERS Well-being Series
01/05/2026
Paper of the Month: May ☀️
“Extent of sinus surgery influences disease control in biologic-treated Type 2 CRSwNP.”
https://onlinelibrary.wiley.com/doi/10.1002/alr.70166
In this study Campion et al. demonstrate that the extent of sinus surgery strongly influences disease control in biologic-treated Type 2 CRSwNP patients.
Patients who underwent extended surgery (Draf IIc/III) achieved significantly better disease control compared to limited surgery, highlighting the importance of surgical completeness alongside optimized biologic therapy.
25/04/2026
ERS Journal Club with international experts
Topic: Update in Rhinology
• Orbital complications of acute rhinosinusitis
• Olfactory implants and emerging technologies
Join us for a discussion of recent and clinically relevant publications in rhinology.
Save the date: May 7, 20:00 CET
We look forward to an engaging discussion!
05/04/2026
Join us for a free ERS webinar on Skull Base!
Speakers:
• Prof Benjamin Verillaud: Endoscopic Treatment of Skull Base Tumors: State of the Art and Future Challenges
• Ralph Abi Hachem: Skull Base Reconstruction in Oncologic Endoscopic Surgery
When: Thursday, the 16th of April, 20:00 CET ⏰
Scan the QR code to join
Or via the link: https://europeanrhinologicsociety.us19.list-manage.com/track/click?u=1dc5f289dd8a7d5fd8c98901b&id=9ca2b52637&e=373509cce5
⭐️
01/04/2026
Paper of the Month: April
A 2-year randomized controlled trial comparing endoscopic posterior nasal neurectomy and radiofrequency ablation in refractory allergic rhinitis.
Both procedures proved to be effective, durable, and safe treatment options, with substantial improvement in symptoms and quality of life.
The choice of procedure may be individualized:
- Neurectomy provided superior and sustained relief of rhinorrhea, nasal congestion, and nasal itching.
- Radiofrequency ablation emerged as a minimally invasive alternative with comparable overall efficacy and quality-of-life improvement.
Particularly interesting is the suggestion that local neural interventions may influence the broader inflammatory burden of allergic respiratory disease through convergent neuroimmune reprogramming.
definitely worth a read 🔥
12/03/2026
We are pleased to invite you to the upcoming ERS webinar from the Valentin Series on Physician Well-Being.
In this session, Barbara Wren will share insights from three decades of developing psychological interventions for doctors and discuss practical perspectives on resilience and well-being in medicine.
Join us on March 19th, 2026 at 20:00 CET for the talk
“How to survive in medicine: what I have learned from 30 years of developing psychological interventions for doctors.”
Registration via the QR code below.
12/03/2026
Paper of the Month: March 🌷
Tissue eosinophilia is a hallmark of chronic rhinosinusitis, particularly in CRSwNP, and plays a central role in disease endotyping and treatment decisions.
In this systematic review and meta-analysis published in Rhinology, Schläpfer et al. demonstrate that oral corticosteroids significantly reduce tissue eosinophil counts in CRS. Importantly, the effect appears consistent across study designs, and higher cumulative corticosteroid doses are associated with lower post-treatment eosinophil levels.
These findings highlight the strong impact of systemic corticosteroids on eosinophilic inflammation and underline their relevance when interpreting tissue eosinophilia and defining inflammatory endotypes in CRS.
Schläpfer NR, Soyka MB, Liechti R, Meerwein CM.
Effect of corticosteroids on tissue eosinophilia in chronic rhinosinusitis: A systematic review and meta-analysis.
Rhinology, 2026.
DOI: 10.4193/Rhin25.097
📗
28/02/2026
We are happy to present a new episode of the Nose Talk😊 🎤 👃🏻
Social Responsibility in Rhinology: Beyond the Operating Theatre
In this episode of Nose Talk, Rory speaks with Prof. Christos Georgalas about social responsibility in rhinology and the wider role of the surgeon beyond the operating theatre. Prof. Georgalas shares his experience volunteering in resource-limited settings and conflict zones, reflecting on the ethical, practical, and emotional challenges of delivering care in difficult environments.
Available on Spotify:
https://spotifycreators-web.app.link/e/If4RkUuqY0b
And now also on Apple Podcasts:
https://podcasts.apple.com/us/podcast/nose-talk-ers-juniors-podcast/id1879321988
04/02/2026
PAPER OF THE MONTH: FEBRUARY ❄️
This NEJM phase 3, randomized, double-blind trial demonstrates that adding tezepelumab to standard care leads to a significantly greater reduction in nasal polyp size and nasal congestion compared with placebo in patients with severe chronic rhinosinusitis with nasal polyps.
The study underscores the growing role of biologic therapies targeting type 2 inflammation and highlights the shift toward more personalized treatment strategies in ENT.